afami-cel
adaptimmune
['afami-cel', 'adaptimmune']
update from adaptimmune on afami-cel, one step closer to bla for a tcr-t. median duration of response of 52 weeks #tcell #asco22 #tcr 
VP, Discovery @ImmunoScape. Cell therapy. Immuno-Oncology. TCR T, CAR T. Opinions are my own.